Thursday, 8 April 2021
Hyderabad: Mexico’s health regulator COFEPRIS (Comisión Federal para la Protección contra Riesgos Sanitarios) has granted approval for emergency use to India’s Covid-19 vaccine, Covaxin.
The news of the approval was tweeted by Mexico’s foreign minister Marcelo Ebrard. “Very timely decision by COFEPRIS to authorise the emergency use of the Covaxin vaccine manufactured in India. The options for vaccination against Covid-19 in Mexico are expanded,” said the post by Ebrard, a translated version of which was retweeted by the Twitter handle of the Indian Embassy in Mexico.
Covaxin now becomes the sixth Covid-19 vaccine to be approved in Mexico after Russia’s Sputnik V, the Pfizer & BioNTech vaccine, AstraZeneca-Oxford vaccine, Sinovac’s Coronavac and CanSino’s vaccine.